Shire Announces Results of its Bioequivalence Study of SPD465, an Investigational Drug for Adults with ADHD
17th Nov 2006, 03:51 GMT
Latest news from PR Newswire: All Releases:
- AXA Announces the Successful Completion of Its First Mortality Risk Securitization Transaction
- "Powder Coatings in Europe 2005/2006-2016 - A New Dawn" Plus a General Overview of the Powder Coatings Markets in the Middle East & Africa
- Tech Industry Innovator Fred Greenberg Joins Veridigm's Board of Directors
- SST Sets New Benchmark With Industry's First 1.8V Ultra Low Power, Ultra Thin SPI Serial Flash Memory Family
- Esaote Harnesses Texas Instruments DSPs to Deliver Next-Generation Medical Diagnostic Systems
- QUALCOMM and Motorola to Collaborate on UMTS Handsets
- SIA Lattelecom Steps up Volumes With Carrier Cockpit(TM)
- Exciting Times for Laboratory Information Systems in the Era of the Electronic Medical Record
- Belgium Cable Investors Exercises Options to Increase Stake in Telenet Group Holding N.V.
- Mercer Survey Finds That Organizations in Greater China Fail to Identify Critical Jobs and Fall Short in Career Development